Alrista Sr Tablet 10

Macleods Pharmaceuticals Pvt.ltd

Strip of 10 Units

MRP ₹169.4

₹138.91

₹16.94/Units

18% off applied
*MRP inclusive of all taxes
Get it By
Change
Choose your location

Use your current location

Login to view saved addresses

100% genuine medicines

Safe & secure payments

15 days Easy returns

Prescription required for this medicine

Store Below 30o C

About Alrista Sr Tablet 10

Alrista SR Tablet is primarily used for managing diabetic neuropathy, a nerve-related complication of diabetes. It falls under a class of medicines known as aldose reductase inhibitors which are known to be effective in managing complications arising from diabetes.

This tablet helps improve nerve function and reduce neuropathic pain in diabetic patients. Chronic high blood sugar levels can lead to damage in the nerves over time, and this tablet helps prevent this nerve damage.

It is crucial that this medicine is taken as directed by your doctor. Make sure to inform your doctor about pre-existing conditions or ongoing medications before starting this medicine. If you observe any side effects while on this medication, notify your doctor immediately. For optimal results, continue taking the medicine for the duration prescribed by your doctor.

Certified Content

Written by

Dr Nikita Lobo
Dr Nikita Lobo

Medical Editor & Reviewer | 7 years

BDS, MDS

Reviewed by

Dr. Chhavi Rosha
Dr. Chhavi Rosha

Health & Medical Content Writer | 8 years

BMS, FMC, MD Resident

Check out Editorial Policy

References

  • Epalrestat: Uses, interactions, mechanism of action | DrugBank Online. (n.d.). DrugBank. https://go.drugbank.com/drugs/DB15293

  • Sharma, S., & Sharma, N. (2008). RETRACTED: Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: An Indian perspective. Annals of Indian Academy of Neurology, 11(4), 231. https://doi.org/10.4103/0972-2327.44558

  • Ramirez, M. A., & Borja, N. L. (2008). Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy. Pharmacotherapy the Journal of Human Pharmacology and Drug Therapy, 28(5), 646–655. https://doi.org/10.1592/phco.28.5.646

  • Shi, W., Xu, G., Gao, Y., Zhao, J., Liu, T., Zhao, J., Yang, H., Wei, Z., Li, H., Xu, A., Bai, Z., & Xiao, X. (2023). Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase. Journal of Translational Medicine, 21(1). https://doi.org/10.1186/s12967-023-04380-4

Was this product description useful?
47 people find this information helpful

Disclaimer

We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.

Subscribe

Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.

Download Truemeds

Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.

playstoreIcon

Contact Us

Our customer representative team is available 7 days a week from 9 am - 9 pm.


v3.4.10

copyright2024 - Truemeds | All rights reserved

Our Payment Partners

paymentPartnerpaymentPartnerpaymentPartnerpaymentPartnerpaymentPartner
paymentPartnerpaymentPartnerpaymentPartnerpaymentPartner